Artelo Biosciences Inc (ARTL : NASDAQ)
Common Stock
$7.31
USD
+3.16 (76.14%)
Last updated: 2026-09-23
Follow ARTL
ARTL
Artelo Biosciences Inc
WealthAwesomePerformance
1 Day
+76.14%
1 Week
+94.93%
1 Month
+17.88%
YTD
-36.05%
Key Statistics
Market Cap
$4.00M
52W High
$161.73
52W Low
$3.45
P/E Ratio
-
50 Day MA
$6.78
200 Day MA
$27.14
Beta
-0.07
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/23/2026 | $4.03 | $15.73 | $3.90 | $7.31 | $7.31 | 25,129,667 |
| 9/22/2026 | $4.14 | $4.20 | $3.86 | $4.15 | $4.15 | 324,281 |
| 9/21/2026 | $3.89 | $4.19 | $3.88 | $4.10 | $4.10 | 73,081 |
| 9/18/2026 | $4.00 | $4.14 | $3.92 | $3.94 | $3.94 | 29,400 |
| 9/17/2026 | $3.84 | $4.02 | $3.69 | $3.97 | $3.97 | 125,237 |
| 9/16/2026 | $4.90 | $4.90 | $3.45 | $3.75 | $3.75 | 275,442 |
| 9/15/2026 | $4.88 | $5.65 | $4.88 | $5.34 | $5.34 | 91,458 |
| 9/14/2026 | $5.28 | $5.49 | $4.86 | $4.87 | $4.87 | 54,916 |
| 9/11/2026 | $5.69 | $5.84 | $5.35 | $5.43 | $5.43 | 41,932 |
| 9/10/2026 | $5.89 | $6.00 | $5.61 | $5.63 | $5.63 | 41,300 |
Analyst Price Targets
Based on 2 analysts covering ARTL · as of Sep 17, 2026
Wall Street analysts forecast ARTL stock price to rise 146.2% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
US$18.00
+146.2% Upside
Current Price
US$7.31
Last close
Analyst Breakdown (2 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ARTL's historical volatility
30-Day Vol
210.2%
Annualized
90-Day Vol
152.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$6.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$6.89 | US$3.33 – US$14.23 |
| 60 trading days | US$6.49 | US$2.33 – US$18.10 |
| 90 trading days | US$6.11 | US$1.74 – US$21.48 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Artelo Biosciences Inc
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-7.44M
- Profit Margin
- 0.00%
- ROE (TTM)
- -705.71%
- EPS (Diluted)
- -102.67
- Book Value
- 10.74
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ARTL.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BENF | Beneficient Class A Common Stock | $2.90 | +438.73% |
| JAGX | Jaguar Animal Health Inc | $8.91 | +233.71% |
| WHLR | Wheeler Real Estate Investment Trust, Inc. | $5.44 | +190.91% |
| VSA | TCTM Kids IT Education Inc. | $3.64 | +83.84% |
| BFRG | Bullfrog AI Holdings, Inc. Common Stock | $0.95 | +58.33% |
| VTGN | VistaGen Therapeutics Inc | $0.37 | +46.54% |
| IPDN | Professional Diversity Network Inc | $5.42 | +38.97% |
| ONCO | Onconetix Inc | $0.91 | +38.93% |